Kathleen Goin insider trades
Open-market stock purchases and sales by Kathleen Goin, Chief Operating Officer at Palvella Therapeutics, Inc, from SEC Form 4 filings since Dec 13, 2024.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Sep 16, 2026 | PVLA Palvella Therapeutics, Inc | Sold | $251K |
| Sep 16, 2026 | PVLA Palvella Therapeutics, Inc | Sold | $151K |
| Sep 16, 2026 | PVLA Palvella Therapeutics, Inc | Sold | $253K |
| Sep 16, 2026 | PVLA Palvella Therapeutics, Inc | Bought (not open market) | $15.4K |
| Sep 16, 2026 | PVLA Palvella Therapeutics, Inc | Bought (not open market) | $19.5K |
| Sep 16, 2026 | PVLA Palvella Therapeutics, Inc | Bought (not open market) | — |
| Sep 16, 2026 | PVLA Palvella Therapeutics, Inc | Bought (not open market) | — |
| Aug 19, 2026 | PVLA Palvella Therapeutics, Inc | Sold | $227K |
| Aug 19, 2026 | PVLA Palvella Therapeutics, Inc | Sold | $303K |
| Aug 19, 2026 | PVLA Palvella Therapeutics, Inc | Sold | $61.2K |
| Aug 19, 2026 | PVLA Palvella Therapeutics, Inc | Sold | $15.9K |
| Aug 19, 2026 | PVLA Palvella Therapeutics, Inc | Sold | $47.3K |
| Aug 19, 2026 | PVLA Palvella Therapeutics, Inc | Bought (not open market) | $15.4K |
| Aug 19, 2026 | PVLA Palvella Therapeutics, Inc | Bought (not open market) | $19.5K |
| Aug 19, 2026 | PVLA Palvella Therapeutics, Inc | Bought (not open market) | — |
| Aug 19, 2026 | PVLA Palvella Therapeutics, Inc | Bought (not open market) | — |
| Jul 15, 2026 | PVLA Palvella Therapeutics, Inc | Sold | $76.8K |
| Jul 15, 2026 | PVLA Palvella Therapeutics, Inc | Sold | $125K |
| Jul 15, 2026 | PVLA Palvella Therapeutics, Inc | Sold | $154K |
| Jul 15, 2026 | PVLA Palvella Therapeutics, Inc | Sold | $287K |
| Jul 15, 2026 | PVLA Palvella Therapeutics, Inc | Bought (not open market) | $15.4K |
| Jul 15, 2026 | PVLA Palvella Therapeutics, Inc | Bought (not open market) | $19.5K |
| Jul 15, 2026 | PVLA Palvella Therapeutics, Inc | Bought (not open market) | — |
| Jul 15, 2026 | PVLA Palvella Therapeutics, Inc | Bought (not open market) | — |
| Jun 17, 2026 | PVLA Palvella Therapeutics, Inc | Sold | $264K |
Companies traded
- PVLA Palvella Therapeutics, Inc: 33 sales, last Sep 16, 2026